Verastem, Inc. (VSTM)
7.72
-0.46
(-5.62%)
USD |
NASDAQ |
Nov 16, 16:00
7.72
0.00 (0.00%)
After-Hours: 20:00
Verastem Shareholders Equity (Quarterly) : 10.10M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 10.10M |
| June 30, 2026 | 49.99M |
| March 31, 2026 | 81.78M |
| December 31, 2025 | 57.20M |
| September 30, 2025 | -15.53M |
| June 30, 2025 | 36.06M |
| March 31, 2025 | -32.43M |
| December 31, 2024 | -28.89M |
| September 30, 2024 | 32.22M |
| June 30, 2024 | 40.01M |
| March 31, 2024 | 46.22M |
| December 31, 2023 | 78.53M |
| September 30, 2023 | 104.34M |
| June 30, 2023 | 122.75M |
| March 31, 2023 | 54.18M |
| December 31, 2022 | 47.39M |
| September 30, 2022 | 62.87M |
| June 30, 2022 | 53.89M |
| March 31, 2022 | 72.77M |
| December 31, 2021 | 87.56M |
| September 30, 2021 | 95.66M |
| June 30, 2021 | 88.20M |
| March 31, 2021 | 102.61M |
| December 31, 2020 | 115.27M |
| September 30, 2020 | 129.77M |
| Date | Value |
|---|---|
| June 30, 2020 | 114.37M |
| March 31, 2020 | 122.98M |
| December 31, 2019 | 7.174M |
| September 30, 2019 | 21.52M |
| June 30, 2019 | 49.31M |
| March 31, 2019 | 88.46M |
| December 31, 2018 | 124.30M |
| September 30, 2018 | 107.61M |
| June 30, 2018 | 126.87M |
| March 31, 2018 | 38.55M |
| December 31, 2017 | 57.68M |
| September 30, 2017 | 40.98M |
| June 30, 2017 | 48.23M |
| March 31, 2017 | 60.47M |
| December 31, 2016 | 72.30M |
| September 30, 2016 | 82.44M |
| June 30, 2016 | 89.07M |
| March 31, 2016 | 95.97M |
| December 31, 2015 | 102.47M |
| September 30, 2015 | 112.24M |
| June 30, 2015 | 125.26M |
| March 31, 2015 | 131.90M |
| December 31, 2014 | 88.77M |
| September 30, 2014 | 88.81M |
| June 30, 2014 | 99.18M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 50.31M |
| Cytokinetics, Inc. | -321.17M |
| Inovio Pharmaceuticals, Inc. | -33.92M |
| Rigel Pharmaceuticals, Inc. | 445.11M |
| United Therapeutics Corp. | 6.276B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 229.64M |
| Total Liabilities (Quarterly) | 219.54M |
| Debt to Equity Ratio | 12.73 |
| Current Ratio | 1.930 |
| Net Debt Paydown Yield | -1.15% |